| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |